Market Update

Generic Drug Makers Gain Support

kalina
01 Nov, 2002
New York City

President Bush's recent proposal to speed up introduction of generic drugs into the market and thus slash costs for consumers, has pushed generic drug stocks into the spotlight.

Dollar-Store Stocks Get Upscale

iliana
25 Oct, 2002
New York City

Though currently they seem overpriced, dollar-store stocks possess some of the solid fundamentals the market is looking for today. And, their prospects have never been brighter.

Touched by an Angel

vanya
24 Oct, 2002
New York City

With private financiers shying away from untried waters, funds are hard to come by even for worthy start-ups. However, all

Under the Microscope: Analog Devices

vicky
23 Oct, 2002
New York City

Analog Devices looks poised to beat market expectations in Q4, but the stock

Prosperous Period Ahead for Big Pharmas

kalina
21 Oct, 2002
New York City

Despite the many concerns associated with big pharmaceuticals, the sector seems to be in good shape for gains in the near future as the market enters its strongest period.

Quiksilver: Surfing Ahead

iliana
11 Oct, 2002
New York City

Based on current earnings estimates the Quiksilver stock seems valued quite fairly at the moment. But rising sales and growth opportunities make the company worthy of a closer look

Biotech Prospects to Brighten by Year End

kalina
10 Oct, 2002
New York City

For the majority of market sectors, September was a very harsh month. The biotech sector too wasn

Market Gloom Takes Its Toll on IPOs

vanya
08 Oct, 2002
New York City

A weak economy, tumbling stock markets and increased scrutiny on Wall Street took a toll on the IPO market in the third quarter. Is there light at the end of this dark tunnel?

Search Engines' Search for Money

vanya
01 Oct, 2002
New York City

Search engines have not only become a widely used daily tool of Internet surfers but also represent big business opportunities. A prime example is, paid search-engine listing.

More Success Ahead for Gilead

kalina
30 Sep, 2002
New York City

Having just achieved its first profitable quarter, and supported by rising sales and launch of a new drug, biotech company Gilead Sciences is poised to attain more success ahead.

Risk Flavor of Organic Food Stocks

iliana
27 Sep, 2002
New York City

Organic food chains Whole Foods and Wild Oats offer consumers products that ensure a healthier way of life. Currently overpriced, their stocks are likely to be long-term favorites

Wireless Start-ups Still Wired to VC Cash

vanya
18 Sep, 2002
New York City

Although gloom hangs over the wireless industry, VCs are still finding some diamonds in the rough

Busy Fall for Biotechs

kalina
17 Sep, 2002
New York City

Important symposiums and regulatory reviews of drugs this September are likely to spark investor interest in biotech stocks and prompt a rally in case of positive developments.

Looking for Flexible Investment Options

vicky
16 Sep, 2002
New York City

In the current depressed market scenario, investors can easily avoid risk by putting money in the bank - but diversified financial stocks appear to be a good, flexible alternative

Wet Seal Beckons Investors

iliana
12 Sep, 2002
New York City

Supported by future growth potential and its current trimmed, attractive valuations, the stock of teen apparel retailer, Wet Seal, seems to be in fine shape to woo investors